Madison Investment Holdings Inc. decreased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 18.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,599 shares of the medical research company’s stock after selling 5,555 shares during the quarter. Madison Investment Holdings Inc.’s holdings in Thermo Fisher Scientific were worth $4,654,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of TMO. Capital Research Global Investors raised its stake in shares of Thermo Fisher Scientific by 29.8% in the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after acquiring an additional 3,973,136 shares during the period. Janus Henderson Group PLC raised its stake in shares of Thermo Fisher Scientific by 2,058.1% in the second quarter. Janus Henderson Group PLC now owns 2,342,046 shares of the medical research company’s stock valued at $408,620,000 after acquiring an additional 2,233,522 shares during the period. Veritas Asset Management LLP raised its stake in shares of Thermo Fisher Scientific by 112.4% in the second quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock valued at $424,095,000 after acquiring an additional 1,286,259 shares during the period. Harbour Capital Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 18,197.5% in the second quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock valued at $6,884,000 after acquiring an additional 1,194,487 shares during the period. Finally, Meritage Group LP purchased a new stake in shares of Thermo Fisher Scientific in the third quarter valued at $201,383,000. Hedge funds and other institutional investors own 86.05% of the company’s stock.

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $192.29 on Thursday. The company has a market cap of $77,749.00, a P/E ratio of 21.31, a P/E/G ratio of 1.78 and a beta of 1.06. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. Thermo Fisher Scientific Inc. has a 12 month low of $139.88 and a 12 month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. The company had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same period last year, the business earned $2.03 EPS. analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.

Several research analysts recently commented on the stock. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. Barclays reaffirmed an “overweight” rating and issued a $215.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Monday, September 25th. Morgan Stanley reiterated an “overweight” rating and set a $220.00 target price on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Cowen reiterated a “buy” rating and set a $200.00 target price on shares of Thermo Fisher Scientific in a report on Friday, September 1st. Finally, Jefferies Group reiterated a “hold” rating and set a $195.00 target price on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. One analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and an average price target of $205.21.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now directly owns 302,577 shares of the company’s stock, valued at approximately $58,016,113.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Madison Investment Holdings Inc. Reduces Position in Thermo Fisher Scientific Inc. (TMO)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/21/madison-investment-holdings-inc-reduces-position-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.